Company Information
- Type:
- Company
- Country:
- Bulgaria
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Global Compact Status:
- Active
- Participant Since
- 11 March 2004
- Next Communication on Progress (COP) due on:
- 31 July 2025
Financial Information
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 11-Dec-2024 | 2024 Communication on Progress | Submitted |
| 21-Jul-2022 | Communication on Progress Sopharma 2021 | Advanced |
| 26-Apr-2022 | Grace Letter | Not applicable |
| 20-Apr-2021 | Sopharma Communication on Progress 2020 | Active |
| 19-Jul-2019 | Communication on Progress Sopharma 2018 ...and still growing | Active |
| 21-Mar-2018 | Communication on Progress Sopharma 2017 | Active |
| 17-Mar-2017 | Communication on Progress | Advanced |
| 18-Mar-2016 | Communication on Progress | Advanced |
| 18-Mar-2015 | Communication on Progress | Active |
| 10-Apr-2014 | COP 2014 - Sopharma AD | Active |
| 17-Apr-2013 | Communication on Progress 2013 Sopharma AD | Learner |
| 19-Apr-2012 | 2012 Communication on Progress Sopharma AD | Active |
| 24-Jan-2011 | 2011 Communication on Progress | Not applicable |
| 10-Jul-2007 | Sopharma Pharmaceuticals Communication on Progress 2006 | Not applicable |
| 10-Jul-2007 | Letter from CEO/Sopharma Pharmaceuticals Communication on Progress 2006 | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.